EMERGING PUBLIC BIOTECH

10X GENOMICS INC (TXG)

Pleasanton, United States · North America
EMERGING PUBLIC BIOTECH
HEADQUARTERS
Pleasanton, United States
TICKER
TXG
SEGMENT
Emerging Public Biotech
THERAPY AREAS
COMPANY OVERVIEW

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium…

10X GENOMICS INC — FULL INTELLIGENCE

Live regulatory signals, patent cliffs, financials, tariff exposure and pipeline — all free on PharmaSignal.

OPEN PLATFORM →